Five New Areas in the Genome That Increase Risk for Asthma

New study has discovered five new regions of the genome that increase the risk of asthma. The study was conducted by an international collaboration of research teams Inserm and Paris Diderot University (France), the University of Chicago (USA), the National Heart and Lung Institute (UK), the University of Colorado Anschutz Medical Campus (USA) and the Trans-National Asthma Genetics Consortium (TAGC) has discovered This study was published in the journal Nature Genetics.

A major finding of this study is that the genetic loci associated with asthma are enriched in epigenetic marks characterizing gene enhancers. Another key element is the shared associations of variants with asthma, auto-immune diseases and diseases with an inflammatory component. The outcomes of this work open new avenues of research with the goal of elucidating the biological mechanisms underlying asthma in relationship with environmental exposures and to promote the development of new therapies.

Asthma is a chronic inflammatory disease that affects more than 300 million people worldwide including 10 to 20 percent of children. It has a significant socio-economic impact. Asthma is characterized by clinical heterogeneity. Asthma results from both genetic predisposition and exposure to environmental and lifestyle factors.

‘The genetic loci associated with asthma are enriched in epigenetic marks characterizing gene enhancers.’

The TAGC study brought together more than 45 research groups from Europe, North America, Mexico, Australia and Japan. It allowed pooling data on millions of DNA polymorphisms (genetic variants) throughout the genome in more than 142,000 asthmatic and non-asthmatic subjects of European, African, Latino and Japanese ancestry. Meta-analyses of genome-wide association studies conducted in these ethnically-diverse populations identified a total of 878 genetic variants belonging to 18 loci associated with asthma risk.

The TAGC study showed that genetic variants associated with asthma are preferentially located near epigenetic markers in immune cells, suggesting a role of these variants in the regulation of immunologically related mechanisms.

Another key element concerns the involvement of several identified candidate genes in the immune response to viruses, thus highlighting the importance of viral infections in the risk of asthma.

The genetic variants associated with asthma have also effects on autoimmune diseases and other diseases with an inflammatory component such as cardiovascular diseases, cancers, neuro-psychiatric diseases, which strengthens the importance of pleiotropy in multifactorial diseases.

In conclusion, these results highlight the importance of large-scale genetic studies to better characterize complex diseases. This study opens new avenues of research aiming at integrating genomic and epigenomic data together with environmental exposures in order to elucidate the physio-pathological mechanisms underlying asthma and to promote the development of new therapies.

Source: Eurekalert

Diagnose Asthma more Accurately with a New Test

The inclusion of fractional exhaled nitrous oxide (FeNO) in asthma diagnosis is showing results with moderate accuracy. FeNo can be a handy tool in asthma diagnosis.

Asthma is a Leading Cause of Hospitalization in Preschoolers

Asthma symptoms affect an estimated 26 million Americans, and it affects almost 1 in 10 children in the U.S.

Exposure to Particulate Matter Increases Risk of Asthma in Children

Exposure to coarse particulate matter (PM10-2.5) puts children at greater risk for asthma.

Digital Self-Guided Breathing Intervention for Asthma

A digital self-guided breathing retraining intervention that offers breathing exercises for asthma patients has been found to improve quality of life.